BME 695L Lecture 16: FDA and EPA Regulatory Issues

02 Dec 2011 | Online Presentations | Contributor(s): James Leary

See references below for related reading. 16.1 Introduction and overview 16.1.1 How does the FDA think about nanomedical systems? 16.1.2 The 2006 Nanotechnology Task Force 16.2 …

https://nanohub.org/resources/12498

What We Know and Don’t Know About the Toxicity of Nanomaterials: Challenges in Developing Experimental Approaches for Safety Assessment

24 Dec 2010 | Online Presentations | Contributor(s): Peter L Goering

This seminar will summarize recent research activities at CDRH/FDA and highlight issues en countered in the characterization and biological responses of some prototypic nanomaterials.

https://nanohub.org/resources/9941

BME 695N Lecture 21: FDA and EPA Regulatory Issues

27 Nov 2007 | Online Presentations | Contributor(s): James Leary

Outline: Introduction and overview How does the FDA think about nanomedical systems? The 2006 Nanotechnology Task Force Some details of the Nanotechnology Task Force Report …

https://nanohub.org/resources/3549

Nanotechnologies, Science and Society: Promises and Challenges

10 May 2007 | Online Presentations | Contributor(s): James Leary

James Leary (2007), "Nanotechnologies, Science and Society: Promises and Challenges," Purdue Bioethics Seminar Series, http://nanohub.org/resources/2691. Bioethics at Purdue The Graduate School …

https://nanohub.org/resources/2691

Nanotechnology and Occupational Safety and Health: What are the Issues, What do we know, and What is NIOSH Doing

21 Nov 2006 | Online Presentations | Contributor(s): Charles L. Geraci

Nanotechnology and Occupational Safety and Health: What are the Issues, What do we know, and What is NIOSH Doing

https://nanohub.org/resources/2008